Press Releases
Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights
Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
OTC Markets Group Welcomes Ceapro Inc. to OTCQX
Ceapro Begins Trading on the OTCQX Best Market
Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research
Ceapro Inc. to Present at the Fall Investor Summit in New York
Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights
Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University
Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada
